TeleCervico Remote Screening of Cervical Neoplasia, NTL (CAT#: STEM-ME-0398-LX)

It complements the high false rate ( approximately 50 % ) of Pap smear as it can raise sensitivity up to 98%, when combined with Pap smear. As of now, it has been proved to be a very effective and economical screening method and more than 5 million women have used the TeleCervico.